Two-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema.
Thi Ha Chau TranStephane VerdunJean François Le RouicJoel UzzanSolange MilazzoLaurent KodjikianAli ErginayPublished in: Clinical ophthalmology (Auckland, N.Z.) (2022)
These results suggest that IAI is beneficial in vitrectomized eyes leading to improvement of visual and anatomical outcome which was maintained for 2 years.